Skip to content
★ Sign in to follow
JY

Jin Yang Pharmaceutical Co., Ltd. Stock: price and insider trades · South Korea

진양제약

KR·Mcap ₩55.1BHealth Care

No insider purchase over the last 90 days. The latest, by 최재준, was filed 09 Jul 2025.

Jin Yang Pharmaceutical Co., Ltd.: what insiders have been doing

Every trade that managers of Jin Yang Pharmaceutical Co., Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. From 31 October 2025 to 31 October 2026, the disclosure feed for Jin Yang Pharmaceutical Co., Ltd. logged 6 filings by 3 insiders.

There is no open-market purchase to report; the filings show 4 sales by 2 insiders. No amount is published for 4 filings, which the totals therefore leave out.

Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 6 filings, this issuer sits below that mark. Since 2021, the database holds 7 purchases and 4 sales by insiders of the company.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
20
Thresholds
n/a
Buy Volume
€5M
7 ops. · all time
Sell Volume
€2M
4 ops. · all time

Who traded when

BuySale
최윤환1 buy2 sales
최재준1 buy2 sales
한국증권금융1 buy
Fundamental score
Ranked 3,023 of 26,911 companies
73.0
score / 100
Value
73
Quality
73
FCF yld-4.0%
Earn yld40%
EV/EBITDA4.0x
ROE16%
Gross mgn65%
Net mgn18%
Debt/EBITDA2.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩3,900
Analyst consensus
·
Income statement
Revenue₩120.7B
Gross profit₩78.2B65% margin
EBITDA₩32.8B27% margin
Net income₩22.3B18.3% margin
Valuation
Beta0.37
Balance sheet & cash
Market cap₩55.1B
Total debt₩76.8B
Free Cash Flow-₩2.2B
Debt / Equity47%
Profitability & ownership
ROE15.8%
ROA0.9%
% insiders40.3%
% institutions0.0%
Last declaration on 5 June 2026
Declarations20 total
  • ▼
    회장Executives(filed)
    €463kest.0DART
    200,000 sharesShareKRXDART:20260605000658
  • ▼
    대량보유자Executives(filed)
    €463kest.0DART
    200,000 sharesKRXDART:20260605000664
  • ▼
    회장Executives(filed)
    €583kest.0DART
    220,000 sharesShareKRXDART:20260518000228
  • ▼
    Executives
    €563kest.0DART
    209,600 sharesKRXDART:20260518000277
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    대량보유자Executives
    €2.0Mest.0DART
    503,690 sharesKRXDART:20250709000470
    Canonical exit: 30 Sept 2025 (T+90)
  • ▲
    대표이사 회장Executives(filed)
    €2.0Mest.0DART
    491,690 sharesShareKRXDART:20250703000217
    Canonical exit: 1 Oct 2025 (T+90)
  • ▲
    Related company / holdingExecutives
    €326kest.0DART
    66,989 sharesKRXDART:20250409001858
    Canonical exit: 10 Apr 2025 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives
    €292kest.0DART
    66,989 sharesKRXDART:20231130001789
    Canonical exit: 11 Feb 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    €270kest.0DART
    66,989 sharesKRXDART:20230725000108
    Canonical exit: 23 Oct 2023 (T+90)
  • ●
    대표이사 회장Executives
    0DART
    ShareKRXDART:20230725000104
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives(filed)
    €311kest.0DART
    66,989 sharesKRXDART:20211130002021
    Canonical exit: 28 Feb 2022 (T+90)
  • ●
    대표이사 회장Executives(filed)
    0DART
    ShareKRXDART:20210326000828
  • ▲
    Related company / holdingExecutives(filed)
    €303kest.0DART
    66,989 sharesKRXDART:20210326000870
    Canonical exit: 24 Jun 2021 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART

20 of 20 declarations

About Jin Yang Pharmaceutical Co., Ltd.

Jinyang Pharmaceutical is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the research and development of medications.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations